Published in Korean J Radiol on February 22, 2010
A simple and robust classification tree for differentiation between benign and malignant lesions in MR-mammography. Eur Radiol (2013) 0.83
A rim-enhanced mass with central cystic changes on MR imaging: how to distinguish breast cancer from inflammatory breast diseases? PLoS One (2014) 0.79
MRI features of breast lymphoma: preliminary experience in seven cases. Diagn Interv Radiol (2015) 0.78
Adjacent vessel sign and breast imaging reporting and data system are valuable for diagnosis of benign and malignant breast lesions. Biotechnol Biotechnol Equip (2014) 0.77
Bilateral analysis of the cross-sectional area of the internal mammary arteries and veins in patients with and without breast cancer on breast magnetic resonance imaging. Insights Imaging (2013) 0.75
Dynamic contrast-enhanced breast magnetic resonance imaging for the prediction of early and late recurrences in breast cancer. Medicine (Baltimore) (2016) 0.75
Breast Contrast Enhanced MR Imaging: Semi-Automatic Detection of Vascular Map and Predominant Feeding Vessel. PLoS One (2016) 0.75
The great mimicker: zona zoster at the mastectomy site causing contralateral intramammary lymph node enlargement. Case Rep Oncol Med (2012) 0.75
Radiological imaging characteristics of intramammary hematological malignancies: results from a german multicenter study. Sci Rep (2017) 0.75
Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology (1991) 30.87
Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med (1998) 20.81
Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46
Angiogenesis. J Biol Chem (1992) 11.29
Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69
Current status of breast MR imaging. Part 2. Clinical applications. Radiology (2007) 2.65
Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology (2007) 2.43
Does size matter? Positive predictive value of MRI-detected breast lesions as a function of lesion size. AJR Am J Roentgenol (2006) 2.11
Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology (1999) 2.11
Breast MR imaging: interpretation model. Radiology (1997) 2.07
Breast MR imaging: computer-aided evaluation program for discriminating benign from malignant lesions. Radiology (2007) 1.50
Enhanced mass on contrast-enhanced breast MR imaging: Lesion characterization using combination of dynamic contrast-enhanced and diffusion-weighted MR images. J Magn Reson Imaging (2008) 1.47
Correlation between high resolution dynamic MR features and prognostic factors in breast cancer. Korean J Radiol (2008) 1.27
Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol (2005) 1.15
Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol (2005) 1.02
Characterization of breast lesions with CE-MR multimodal morphological and kinetic analysis: comparison with conventional mammography and high-resolution ultrasound. Eur J Radiol (2008) 1.01
MRI of the breast for the detection and assessment of the size of ductal carcinoma in situ. Korean J Radiol (2007) 0.96
MR imaging of mammographically detected clustered microcalcifications: is there any value? Radiology (1998) 0.96
Clustered breast microcalcifications: evaluation by dynamic contrast-enhanced subtraction MRI. J Comput Assist Tomogr (1996) 0.93
Breast MRI for evaluating patients with metastatic axillary lymph node and initially negative mammography and sonography. Korean J Radiol (2007) 0.92
Breast imaging and reporting data system (BIRADS): magnetic resonance imaging. Eur J Radiol (2006) 0.92
Proton MRS of the breast in the clinical setting. NMR Biomed (2009) 0.91
The variability of fibroadenoma in contrast-enhanced dynamic MR mammography. AJR Am J Roentgenol (1997) 0.91
Gadobenate dimeglumine as a contrast agent for dynamic breast magnetic resonance imaging: effect of higher initial enhancement thresholds on diagnostic performance. Invest Radiol (2008) 0.89
Investigation of breast cancer using two-dimensional MRS. NMR Biomed (2009) 0.89
Human in-vivo 31P MR spectroscopy of benign and malignant breast tumors. Korean J Radiol (2001) 0.87
The adjacent vessel on dynamic contrast-enhanced breast MRI. AJR Am J Roentgenol (2006) 0.86
Assessment of tumor angiogenesis in invasive breast carcinomas: absence of correlation with prognosis and pathological factors. Virchows Arch (2000) 0.85
The hook sign for differential diagnosis of malignant from benign lesions in magnetic resonance mammography: experience in a study of 1084 histologically verified cases. Acta Radiol (2010) 0.79
Pathologic correlates of false positive breast magnetic resonance imaging findings: which lesions warrant biopsy? Am J Surg (2005) 0.78
[MR mammography--a critical stocktaking]. Rofo (1996) 0.77
Monitoring the response of circulating epithelial tumor cells to adjuvant chemotherapy in breast cancer allows detection of patients at risk of early relapse. J Clin Oncol (2008) 3.64
Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group. Eur J Cancer (2010) 2.62
Cardiac involvement in Churg-Strauss syndrome: impact of endomyocarditis. Medicine (Baltimore) (2009) 2.14
Establishment of a multicolour fluorescence in situ hybridisation-based assay for subtyping of renal cell tumours. Eur Urol (2013) 2.00
A specific gene expression signature characterizes metastatic potential in clear cell renal cell carcinoma. J Urol (2011) 1.91
Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology (2014) 1.70
Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop. Eur J Endocrinol (2005) 1.66
Thermal ablation of tumors using magnetic nanoparticles: an in vivo feasibility study. Invest Radiol (2002) 1.61
Synergistic antitumor effects of combined cathepsin B and cathepsin Z deficiencies on breast cancer progression and metastasis in mice. Proc Natl Acad Sci U S A (2010) 1.60
In vivo molecular imaging of experimental joint inflammation by combined (18)F-FDG positron emission tomography and computed tomography. Arthritis Res Ther (2010) 1.60
Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol (2007) 1.58
Antinociceptive effects of tumor necrosis factor alpha neutralization in a rat model of antigen-induced arthritis: evidence of a neuronal target. Arthritis Rheum (2008) 1.53
Ultrasound-guided biopsy of homogenous solid renal masses. Eur Urol (2007) 1.44
False-positive findings at contrast-enhanced breast MRI: a BI-RADS descriptor study. AJR Am J Roentgenol (2010) 1.42
Potent anti-inflammatory and antinociceptive activity of the endothelin receptor antagonist bosentan in monoarthritic mice. Arthritis Res Ther (2011) 1.42
Standardized quantification of circulating peripheral tumor cells from lung and breast cancer. Clin Chem Lab Med (2005) 1.40
Assessment of skeletal age at the wrist in children with a new ultrasound device. Pediatr Radiol (2005) 1.35
The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4+CD25+ T cells. Arthritis Res Ther (2005) 1.34
Diffusion tensor imaging: the normal evolution of ADC, RA, FA, and eigenvalues studied in multiple anatomical regions of the brain. Neuroradiology (2009) 1.33
Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol (2005) 1.27
Quantification of the response of circulating epithelial cells to neodadjuvant treatment for breast cancer: a new tool for therapy monitoring. Breast Cancer Res (2005) 1.22
Nonplatinum topotecan combinations versus topotecan alone for recurrent ovarian cancer: results of a phase III study of the North-Eastern German Society of Gynecological Oncology Ovarian Cancer Study Group. J Clin Oncol (2008) 1.19
Potential MRI interpretation model: differentiation of benign from malignant breast masses. AJR Am J Roentgenol (2005) 1.15
Wallerian degeneration of pyramidal tract after paramedian pons infarct. Cerebrovasc Dis (2010) 1.15
Benefit of a 17-year long-term bisphosphonate therapy in a patient with Gorham-Stout syndrome. Arch Orthop Trauma Surg (2008) 1.15
Near-infrared fluorescence imaging of HER-2 protein over-expression in tumour cells. Eur Radiol (2004) 1.12
Influence of breast lesion size and histologic findings on tumor detection rate of a computer-aided detection system. Radiology (2003) 1.11
Quantitative multiplex PCR assay for the detection of the seven clinically most relevant high-risk HPV types. J Clin Virol (2009) 1.09
Cortical blindness after contrast-enhanced CT: complication in a patient with diabetes insipidus. AJNR Am J Neuroradiol (2003) 1.07
Case report: primary carcinoid tumor of the testicle without metastases in combination with testicular atrophy and testosterone deficiency. Int Urol Nephrol (2006) 1.06
Early diagnosis of cerebral involvement in Sturge-Weber syndrome using high-resolution BOLD MR venography. Pediatr Radiol (2004) 1.05
Influence of image-capturing parameters on digital X-ray radiogrammetry. J Clin Densitom (2005) 1.04
Heating potential of iron oxides for therapeutic purposes in interventional radiology. Acad Radiol (2002) 1.03
Further signs in the evaluation of magnetic resonance mammography: a retrospective study. Invest Radiol (2005) 1.02
Cryotherapy of breast cancer under ultrasound guidance: initial results and limitations. Eur Radiol (2002) 1.02
In vivo imaging of experimental arthritis with near-infrared fluorescence. Arthritis Rheum (2004) 1.02
Time course of diffusion imaging in acute brainstem infarcts. J Magn Reson Imaging (2007) 1.01
Expression of the E-cadherin repressors Snail, Slug and Zeb1 in urothelial carcinoma of the urinary bladder: relation to stromal fibroblast activation and invasive behaviour of carcinoma cells. Histochem Cell Biol (2012) 1.00
Breast MRI as an adjunct to mammography: Does it really suffer from low specificity? A retrospective analysis stratified by mammographic BI-RADS classes. Acta Radiol (2010) 1.00
Ultrasound-guided, percutaneous cryotherapy of small (< or = 15 mm) breast cancers. Invest Radiol (2005) 0.99
Gait abnormalities differentially indicate pain or structural joint damage in monoarticular antigen-induced arthritis. Pain (2009) 0.99
Differential effects of locally and systemically administered soluble glycoprotein 130 on pain and inflammation in experimental arthritis. Arthritis Res Ther (2010) 0.99
Diffusion tensor magnetic resonance imaging of the breast: a pilot study. Eur Radiol (2010) 0.99
Time-resolved functional 1H MR spectroscopic detection of glutamate concentration changes in the brain during acute heat pain stimulation. Neuroimage (2009) 0.99
Trial of the cysteine cathepsin inhibitor JPM-OEt on early and advanced mammary cancer stages in the MMTV-PyMT-transgenic mouse model. Biol Chem (2008) 0.98
Resolving arterial phase and temporal enhancement characteristics in DCE MRM at high spatial resolution with TWIST acquisition. J Magn Reson Imaging (2011) 0.97
Iron oxide-based nanostructures for MRI and magnetic hyperthermia. Nanomedicine (Lond) (2012) 0.97
Demonstration of paramagnetic and diamagnetic cerebral lesions by using susceptibility weighted phase imaging (SWI). Z Med Phys (2006) 0.96
The anti-inflammatory effects of sympathectomy in murine antigen-induced arthritis are associated with a reduction of Th1 and Th17 responses. Ann Rheum Dis (2011) 0.95
FISH analysis of washing urine from the upper urinary tract for the detection of urothelial cancers. Int Urol Nephrol (2014) 0.95
Characterization of iron oxide nanoparticles adsorbed with cisplatin for biomedical applications. Phys Med Biol (2009) 0.93
Sensitivity and specificity of unenhanced MR mammography (DWI combined with T2-weighted TSE imaging, ueMRM) for the differentiation of mass lesions. Eur Radiol (2009) 0.93
Diagnosis of arthritis using near-infrared fluorochrome Cy5.5. Invest Radiol (2004) 0.93
MR Imaging in Wegener granulomatosis of the spinal cord. AJNR Am J Neuroradiol (2003) 0.93
Radio-frequency tumor ablation: internally cooled electrode versus saline-enhanced technique in an aggressive rabbit tumor model. Radiology (2002) 0.92
Assessing the efficacy of targeted therapy using circulating epithelial tumor cells (CETC): the example of SERM therapy monitoring as a unique tool to individualize therapy. J Cancer Res Clin Oncol (2010) 0.92
Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinoma. J Urol (2011) 0.92
Computerized quantification of joint space narrowing and periarticular demineralization in patients with rheumatoid arthritis based on digital x-ray radiogrammetry. Invest Radiol (2006) 0.92
In vivo near-infrared fluorescence imaging of carcinoembryonic antigen-expressing tumor cells in mice. Radiology (2008) 0.91
Normative data for digital X-ray radiogrammetry from a female and male German cohort. J Clin Densitom (2006) 0.91
Liposomal encapsulation enhances and prolongs the anti-inflammatory effects of water-soluble dexamethasone phosphate in experimental adjuvant arthritis. Arthritis Res Ther (2010) 0.91
Computerized digital imaging techniques provided by digital X-ray radiogrammetry as new diagnostic tool in rheumatoid arthritis. J Digit Imaging (2006) 0.90
Hepatic Fibrosis in a Long-term Murine Model of Sepsis. Shock (2012) 0.90
Differential diagnosis of breast lesions 5 mm or less: is there a role for magnetic resonance imaging? J Comput Assist Tomogr (2010) 0.90
Magnetic resonance imaging of inflammatory breast carcinoma and acute mastitis. A comparative study. Eur Radiol (2008) 0.89
Echocardiography signs of early cardiac impairment in patients with breast cancer and trastuzumab therapy. Clin Res Cardiol (2012) 0.89
Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO. Cancer Chemother Pharmacol (2007) 0.89
Changes in magnetic resonance mammography due to hormone replacement therapy. Breast Cancer Res (2004) 0.89
An in vitro characterization study of new near infrared dyes for molecular imaging. Eur J Med Chem (2009) 0.88
Voiding urosonography with ultrasonography contrast medium in children. Pediatr Nephrol (2002) 0.88
Computer-aided joint space analysis of the metacarpal-phalangeal and proximal-interphalangeal finger joint: normative age-related and gender-specific data. Skeletal Radiol (2007) 0.88
Magnetic resonance-guided large-core breast biopsy inside a 1.5-T magnetic resonance scanner using an automatic system: in vitro experiments and preliminary clinical experience in four patients. Invest Radiol (2005) 0.88
Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol (2011) 0.88
Fluorescent bacterial magnetic nanoparticles as bimodal contrast agents. Invest Radiol (2007) 0.88
Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1). Arthritis Res Ther (2006) 0.87
Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent. Eur Radiol (2010) 0.87